DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that the Company will report financial results for the second quarter ended June 30, 2010 on Monday, August 9, 2010 following the close of the financial markets. The announcement will be followed by a conference call conducted by Neoprobe’s President and CEO, David Bupp, and Senior Vice President and CFO, Brent Larson, scheduled for Monday, August 9, 2010 at 5:00 PM ET. The conference call can be accessed as follows:
